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ABSTRACT
Translation termination requires eRF1 and eRF3 for
polypeptide- and tRNA-release on stop codons. Addi-
tionally, Dbp5/DDX19 and Rli1/ABCE1 are required;
however, their function in this process is currently
unknown. Using a combination of in vivo and in vitro
experiments, we show that they regulate a stepwise
assembly of the termination complex. Rli1 and eRF3-
GDP associate with the ribosome first. Subsequently,
Dbp5-ATP delivers eRF1 to the stop codon and in this
way prevents a premature access of eRF3. Dbp5 dis-
sociates upon placing eRF1 through ATP-hydrolysis.
This in turn enables eRF1 to contact eRF3, as the
binding of Dbp5 and eRF3 to eRF1 is mutually ex-
clusive. Defects in the Dbp5-guided eRF1 delivery
lead to premature contact and premature dissoci-
ation of eRF1 and eRF3 from the ribosome and to
subsequent stop codon readthrough. Thus, the step-
wise Dbp5-controlled termination complex assem-
bly is essential for regular translation termination
events. Our data furthermore suggest a possible role
of Dbp5/DDX19 in alternative translation termination
events, such as during stress response or in develop-
mental processes, which classifies the helicase as a
potential drug target for nonsense suppression ther-
apy to treat cancer and neurodegenerative diseases.
INTRODUCTION
When a ribosome arrives at a stop codon on the mRNA,
protein synthesis is terminated and the peptide is released
(1). In eukaryotes, two essential release factors are well
known to mediate translation termination. The eukaryotic
release factor 1 (eRF1), in Saccharomyces cerevisiae en-
coded by SUP45, is the only class I termination factor in
eukaryotes that recognizes all three different stop codons
(UAG, UAA, UGA) and subsequently mediates the hy-
drolysis of the peptidyl-tRNA in the ribosomal peptidyl-
transferase center (PTC). In addition, the class II eukary-
otic release factor 3 (eRF3), in S. cerevisiae encoded by
SUP35, enhances translation termination efficiency with its
GTPase activity (2,3). Most termination models (Supple-
mentary Figure S1A) anticipate that eRF1 and eRF3–GTP
enter the ribosome together as a ternary complex once the
stop codon is reached (1,2,4), as both factors strongly in-
teract with each other via their C-terminal domains (5,6).
Supposedly, successful stop codon recognition by eRF1 in-
duces GTP-hydrolysis of eRF3, which in turn leads to a
conformational rearrangement in eRF1 resulting in its ac-
tive form, which positions its GGQ-motif in the PTC and
mediates hydrolysis of the ester bond of the peptidyl-tRNA
(7–9).
In light of these mostly in vitro studies, nothing seems to
be missing; however, novel factors essential for translation
termination in vivowere discovered and need to be incorpo-
rated into a comprehensive model: The DEAD-box RNA
helicase Dbp5, encoded by RAT8 (human DDX19) (10),
its stimulating co-factors Gle1 plus inositol hexakisphos-
phate IP6 (11,12), the iron-sulfur containing ATP-binding
cassette protein Rli1 (human ABCE1) (13,14) and the initi-
ation factor eIF3, including Hcr1 (15). Dbp5 and Gle1 are
well known for their function in mRNA-export through nu-
clear pore complexes (NPCs) (16). Using its regulated AT-
Pase cycle, Dbp5 remodels RNA–protein complexes at the
cytoplasmic side of the NPC on emerging mRNAs (17).
By dissociation of the export receptorMex67-Mtr2 (human
TAP-p15) from the arriving mRNAs, its backsliding is pre-
vented and directionality of the transport event established.
Its co-factors Gle1 and IP6 stimulate ATP-hydrolysis lead-
ing to RNP-release and binding of Dbp5-ADP to the NPC-
protein Nup159 (human Nup214). Importantly, this bind-
ing leads to ADP-release, a conformational change and the
binding of ATP (16,17). The ATPase activity of Dbp5 is
also essential for efficient translation termination (10,12).
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In addition to these functions, Dbp5 plays also a role in the
export of both ribosomal subunits (18). However, in con-
trast, to mRNA export and translation termination, Dbp5
acts independently of itsATPase activity in ribosome export
(18).
Rli1 functions in biogenesis and nuclear export of pre-
ribosomal subunits (19–21), translation initiation (22), ter-
mination (13) and in particular in ribosome recycling (23).
Rli1 is a solublemember of theATP-binding cassette (ABC)
protein superfamily that contains two nucleotide-binding
domains (NBDs) and two N-terminal iron-sulfur clusters.
A hinge domain connects both NBDs forming a cleft,
which is open in the ADP-bound state, while ATP-binding
induces its closure with a concomitant movement of the
iron-sulfur domain allowing ATP-hydrolysis. This ATP-
dependent tweezers-like motion converts chemical energy
into mechanical power, which is important for splitting the
ribosome into its ribosomal subunits (24). The protein is
highly conserved in eukaryotes and essential in all organ-
isms tested (22). Interestingly, Rli1 acts ATP-hydrolysis in-
dependent during translation termination (13,25). It was
suggested that Rli1 associates with the termination complex
upon dissociation of eRF3–GDP, taking over its position to
keep eRF1 in its favourable position to facilitate peptidyl-
tRNA hydrolysis (4,26).
The initiation factor eIF3 has recently been associated
with translation termination, because mutations in its sub-
units reduce the rate of stop codon readthrough (15). In-
terestingly, deletion of the substoichiometric component
HCR1 shows an increased readthrough activity and this
phenotype was suppressed by high copyRLI1. Amodel was
proposed in which Hcr1 is not a bona fide translation ini-
tiation factor, but rather acts in termination by promoting
GDP–eRF3 ejection from the ribosomes (15).
So far, no translation termination model is available that
includes all of these factors that support termination and
many results were obtained from in vitro assays with pu-
rified components. Therefore, we analysed the process in
S. cerevisiae in vivo and in vitro with all participating fac-
tors and uncovered a sequential recruitment mechanism, in
which Rli1 and eRF3 wait at the ribosome for the entry of
Dbp5 that delivers eRF1 and at the same time shields it from
premature access of eRF3. Upon proper positioning Dbp5
dissociates, allowing eRF3 to contact and stimulate eRF1
activity. This stepwise entry of the termination factors and
in particular the Dbp5 controlled eRF1–eRF3 interaction,
prevents premature and inefficient translation termination.
MATERIALS AND METHODS
Yeast strains and plasmids
All S. cerevisiae strains, plasmids and oligonucleotides used
in this study are listed in the ExpandedView Supplementary
Tables S1, S2 and S3, respectively. For growth analyses, cells
were spotted in 10-fold serial dilutions onto selective agar
plates and grown for 3 days at the indicated temperatures.
The strains, HKY1622 and HKY1623, were gener-
ated by crossing HKY1271 (RLI1-GFP) and HKY446
(sup45-2). Crossing the strains HKY445 (WT of HKY446)
or HKY446 with the strain HKY1122 (Prt1-GFP) pro-
duced the strain HKY1915 and the corresponding WT
HKY1914. The strain HKY1921 was generated by crossing
the strains HKY477 (rat8-2-myc) and HKY1907 (trp5Δ)
and exchange of pHK629 with pHK693. For the genera-
tion of plasmid pHK1292, the GFP ORF was amplified
by polymerase chain reaction using the primers HK1194
and HK1195 and inserted via XhoI and PstI sites into
pHK887 (2μRli1-HALEU2) replacing the HA-tag. To cre-
ate pHK1474 and pHK1475, theRLI1-GFPORFwith pro-
moter and terminator was amplified from pHK1292 with
the primers HK2136 and HK2137 and inserted via Gib-
son assembly reaction into pHK86 and pHK87, respec-
tively, which were linearized by SacI and SalI digestion.
The GLE1 ORF was amplified from gDNA with HK1398
and HK1399 and inserted via BamHI site into pHK825
(CEN PADH13xMYC URA3) to generate pHK1323. For
the generation of pHK1283, the SUP35 ORF was ampli-
fied with the primers HK1109 and HK1110 and inserted
via EcoRI and XhoI sites into pGEX-4T-1. The SUP45
ORFwas amplified with the primers HK1144 and HK1156
and inserted via NdeI and XhoI sites into pET28a to cre-
ate pHK1280. The SUP45Δ1237-1311 ORF was amplified
with the primers HK1146 and HK1147 and inserted via
BamHI and XhoI sites into pET15b to generate pHK1278.
To generate pHK1394, the GLE1 ORF was amplified with
the primers HK1613 and HK1614 and inserted via Gibson
assembly reaction into pETMBP1 1a that was linearized by
SacI and NcoI digestion.
Co-immunoprecipitation experiments
In vivo interactions studies were carried out following the
protocols published previously (18,27). For immunoprecip-
itation ofGFP-tagged proteins, 10l slurry ofGFP-Trap A
beads (Chromotek) and for TAP-tagged proteins, 20 l
slurry of IgG-Sepharaose beads (GEHealthcare) were used
per reaction and incubated with 200 (high abundant pro-
teins) and up to 2000 l (for low abundant proteins) of the
clarified lysate for 3 h rotating at 4◦C. If indicated, the sam-
ples were treated with 0.2 mg/mlRNase A (AppliChem) for
additional 30 min at 4◦C. Finally, the eluted proteins were
separated on 10% SDS-polyacrylamide gels and analysed
by western blotting.
Sucrose-density gradient fractionation
The experiments were essentially performed as described
previously (18) with the following modifications. For elon-
gation factor mutants, no cycloheximide treatment was per-
formed meaning that cells were directly harvested upon 1 h
temperature shift, cycloheximide was omitted from the ly-
sis buffer. For protein analyses, 15 OD260nm units of lysates
were loaded onto the top of linear 7–47% (w/v) sucrose gra-
dients and centrifuged for 2 h and 40 min at 40 000 rpm and
4◦C in a TH-641 rotor and Sorvall WX80 ultracentrifuge
(Thermo Scientific). After gradient fractionation, protein
fractions were precipitated with 10% trichloroacetic acid,
washed twice with 80% aceton and subjected to sodium
dodecylsulphate-polyacrylamide gel electrophoresis (SDS-
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Western blot analyses and quantification
Polyclonal rabbit antibodies against Dbp5 (dilution
1:1000), eRF1 and eRF3 (kindly provided by D. Bedwell,
dilution for both 1:1000), uL29 = Rpl35 and uS3 =
Rps3 (kindly provided by M. Seedorf, dilution 1:5000
and 1:10 000 respectively, or anti-Rps3 peptide antibody
1:500), Aco1, Hem15, Por1 and Zwf1 (kindly provided
by R. Lill, dilution 1:1000, 1:7000, 1:2000, and 1:4000,
respectively), Asc1 (kindly provided by G. Braus, dilution
1:2000) and Cdc28 (sc-28550; Santa Cruz, dilution 1:2000)
were used. GFP-tagged proteins were detected with anti-
GFP antibodies (sc-8334; Santa Cruz, dilution 1:1000),
or GF28R (Pierce Protein Biology, 1:5000), or (ab183734;
Abcam; 1:10 000), MYC-tagged proteins with an anti-
MYC antibody (sc-789; Santa Cruz, dilution 1:750) and
HA-tagged proteins with an anti-HA antibody (sc-57592
and sc-7392; Santa Cruz, dilution 1:750) and GST-tagged
proteins with an anti-GST antibody (sc-138; Santa Cruz,
dilution 1:2000). Secondary anti-rabbit IgG (H+L)-HRPO
and anti-mouse IgG (H+L)-HRPO (Dianova) antibodies
were used and detected with Amersham ECL Prime
Western Blotting Detection Reagent (GE Healthcare)
or WesternBright Chemilumineszenz Substrat Quantum
(Biozym) and the FUSION-SL chemiluminescence detec-
tion system (Peqlab). Quantification of western blot signals
was performed with the Bio1D software (Peqlab) or with
ImageStudio Lite (Li-COR Biosciences). For statistical
analyses of co-immunoprecipitation studies, the intensity of
co-precipitated bands was related to that of the pull-down
and finally, the ratio of the mutant or treated strains was
compared to the wild typical ratio. For quantification of
the sucrose density gradient fractionation experiments, the
intensity of each fraction was measured and the polysomal
fractions were compared to the sum of the 80S, 60S, 40S
and non-ribosomal fractions.
In vitro binding studies
GST-Dbp5, GST-eRF1 and GST-eRF3N65, a more sta-
ble version of eRF3 that has a truncated C-terminus,
were expressed in Escherichia coli Rosetta 2 cells, purified
by affinity chromatography with GSTrap 4B Glutathione
Sepharose (GE Healthcare) and stored at −80◦C in elution
buffer (for GST-Dbp5: 50 mM Tris pH 7.5, 150 mMNaCl,
30 mM Glutathione reduced) (for GST-eRF1 and GST-
eRF3: 20 mMHEPES pH 7.5, 500 mMNaCl, 5% glycerol,
4 mM -MeOH, 30 mM Glutathione reduced). To obtain
untagged Dbp5, eRF1 and eRF3, the purified GST-tagged
proteins were cleaved with PreScission protease overnight
at 4◦C. Afterwards, GST was removed by performing a sec-
ond affinity chromatography with GSTrap 4B Glutathione
Sepharose (GE Healthcare). The proteins were further pu-
rified by running the collected flow through over a gel filtra-
tion chromatography. Purified GST–Dbp5 and Dbp5 were
stored in 50mMTris pH 7.5, 150mMNaCl, 10% glycerol at
−80◦C, whereas GST-eRF1, eRF1, GST- eRF3 and eRF3
were stored in 50 mM NaCl pH 7.5, 20 mM HEPES, 5%
glycerol and 4 mM -MeOH at 80◦C.
For binding studies either purified proteins as indicated
above were used or Rosetta II (DE3) cells were trans-
formed with pET15b-HIS6-SUP45 delta 25 (eRF1 lacking
25aa at the C-terminus), pET28a-HIS6-SUP45, pGEX4T1-
GST-SUP35, pGEX-6P-1-GST-RLI1 and pGEX6P1-GST.
Overexpression was induced by growing the cells for 3 days
in auto-inducingmedia (LBmedia with 0.5% (v/v) glycerol,
0.05% (v/v) Ggucose and 0.2% (v/v) lactose plus 25 mM
K2HPO4, 25 mM NaH2PO4, 50 mM NH4Cl and 0.5 mM
Na2SO4) at 16◦C. Cells were harvested and resuspended in
lysis buffer (50mMTris–HCl, pH 7.5, 150mMNaCl, 2mM
MgCl, 5% (v/v) glycerol, 1 mMDithiothreitol (DTT), 0.2%
(v/v) NP-40 and ethylenediaminetetraacetic acid (EDTA)-
free protease inhibitor mix (Roche)). After cell lysis by soni-
cation and centrifugation, the supernatant was used for fur-
ther analysis. The used GSTrap 4B Glutathione Sepharose
(GE Healthcare) beads were pre-incubated with 3% Albu-
min Fraction V (Roche) and mixed with lysis buffer. Next,
the GST tagged proteins or only GST were incubated with
15 l slurry of GSTrap for 2 h at 4◦C. After several washing
steps with buffer (excluding protease inhibitor), the beads
were incubated with the protein lysates for additional 2 h
at 4◦C. For the competition assay, the eRF1 lysate was first
incubated with GST-Dbp5 bound to the GSTrap for 20 min
at 4◦C, before adding purified eRF3N65 in the indicated
amounts and further incubation for 1 h at 4◦C. After five
washing steps with lysis buffer, the proteins that were bound
to the beads were analysed by SDS-PAGE andwestern blot.
Prt1-GFP and Nip1-GFP were purified from yeast cells
before the in vitro binding assay was carried out with recom-
binantly expressed GST-Rli1.
Readthrough assay
The dual reporter -galactosidase luciferase assay was basi-
cally performed as described previously (10,28). Briefly, all
analysed yeast strains were transformed with the reporter
plasmids pHK607 or pHK608, respectively. Yeast cells were
grown at 25◦C to mid-log phase, shifted for 30 min to 37◦C
and afterward divided: 20OD600 were used for the luciferase
assay and 50 ml that were split for triplicates for the -
galactosidase assay,
The luciferase assay was performed with the ‘Beetle-Juice
Luciferase Assay Firefly’ kit (p.j.k GmbH) according to the
manufacturer’s protocol. For that, cell pellets were lysed
with 300 l glass beads in a FastPrep-24 machine (MP
Biomedical) in 400 l lysis buffer (77 mM K2HPO4, 23
mM KH2PO4, 0.2% Triton X-100, 1 mM DTT) supple-
mentedwithComplete, EDTA-free protease inhibitor cock-
tail (Roche). The lysates were centrifuged twice for 5 min at
21 000 × g and 4◦C. Afterwards, 20 l of the cleared lysate
was transferred in triplicate into a white 96-well plate, sup-
plemented with always 50 l substrate and measured with
the luminometer (Victor X3 2030 multilabel reader from
Perkin Elmer).
For the -galactosidase assay, all cell pellets were resus-
pended in 300 l of Z-buffer (100 mM phosphate buffer
pH 7.0, 10 mM KCl, 1 mM MgSO4) and lysed with the
freeze-and-thaw method (1 min in liquid nitrogen, 2 min in
37◦C water bath, four times repeated). Afterwards, 700 l
of Z-buffer with 1 mM DTT and 160 l of the substrate
ONPG (4 mg/ml of o-Nitrophenyl--D-galactopyranosid
in Z-buffer) were added and incubated at 30◦C until colour
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tion of 1 M Na2CO3 and the OD420nm was measured with
a spectrophotometer (UV-1601 from Shimadzu). The rela-
tive readthrough activity was calculated from the ratio of lu-
ciferase to -galactosidase activity measured with the stop
codon-containing reporter related to the ratio from the in-
frame control.
Statistical analysis
Quantification was performed for at least three independent
experiments. Quantification of co-immunoprecipitation ex-
periments shown in Figures 1D, 2C, E, 3C, E, 4B, C, E, G
6D,G and I were analysed for significance by Student’s two-
tailed, two-sample, unequal variance t-test. In all cases, each
dataset was normalized and only compared to wild-type.
The mean ± standard deviations are displayed. The same
was done for Figures 1G, 2H and 6B, with the exception
that the differences were analysed by a Student’s one-tailed,
two-sample, unequal variance t-test. In Figures 1G and 6B,
the signal intensity of the analysed proteins in the polysomal
fraction of the tef2-9 strain was subtracted from the wild-
type signals in the polysoms of the respective protein and
normalized to the Asc1/uS3 protein content that reflected
the amount of polysomes. All data were finally analysed for
significance by Student’s two tailed, two-sample, unequal
variance t-test. Significance P-values below 0.05 were indi-
cated by asterisks (*P < 0.05; **P < 0.01; ***P < 0.001).
RESULTS
Binding of Dbp5, but not Rli1, to the termination complex
depends on eRF1
Previous studies of the translation termination process have
not revealed, how and when Rli1 and Dbp5 are recruited
to the terminating ribosome. Crystal structure and in vitro
analyses with purified proteins proposed that Rli1 and
eRF3 bind to the same position on the terminating ribo-
some so that their association seemed to be mutually ex-
clusive and it was suggested that Rli1 might take over the
binding site of eRF3 after its dissociation to catalyse the
subsequent ribosome recycling (4,29) (Supplementary Fig-
ure S1B). However, a potentially earlier association of Rli1
with the ribosome before ribosome recycling has not been
investigated. The same is unclear for Dbp5. The helicase
might already be associated with elongating ribosomes or it
could be recruited at a later step together with eRF1 upon
arrival of the ribosome at the stop codon. To address these
questions, we analysed the ribosomal association of Rli1
and Dbp5 in the temperature-sensitive eRF1mutant sup45-
2 that is defective in translation termination and in ribo-
some binding. Upon a temperature shift to 37◦C, ribosome
binding of the mutated eRF1 protein sup45-2 is disturbed,
resulting in stop codon recognition defects and subsequent
readthrough activity in which near-cognate tRNAs are in-
corporated at the termination codon and translation elon-
gation continues to the next stop codon (30). If Rli1 would
enter the termination process after eRF1 has entered, one
would expect to see a reduced binding of Rli1 to ribosomes
in that mutant. However, co-immunoprecipitation experi-
ments (co-IPs) show that the binding of Rli1 to the large
ribosomal protein uL29 (yeast Rpl35) is unchanged and
its association with the small ribosomal protein uS3 (yeast
Rps3) is even increased in sup45-2 cells (Figure 1A and D).
These results indicate that Rli1 binds ribosomal particles
without functional eRF1 and that it is possibly associated
with ribosomes before eRF1 enters. The increased binding
of Rli1 to the 40S subunit in sup45-2might represent an en-
hanced presence of 43S pre-initiation complexes, which are
stabilized by Rli1 (22). In contrast to Rli1, the interaction
of Dbp5 and the mutated eRF1 protein with both riboso-
mal proteins is reduced in sup45-2 (Figure 1B–D) suggesting
that Dbp5 requires functional eRF1 for its association with
terminating ribosomes. This reduced ribosomal association
might be due to the fact that mutant eRF1 is rather unstable
and only∼50%of the protein amount is detectable in lysates
on western blots (Figure 1C). Thus, while the association of
Rli1 with the ribosome rather increases in sup45-2 cells, the
association of Dbp5 and mutant eRF1 decreases. These re-
sults might indicate that Rli1 associates with the ribosome
before Dbp5 and eRF1.
To verify this sequential recruitment, we analysed
whether Rli1, but not Dbp5 associates with ribosomes ar-
rested in translation elongation and found that this is indeed
the case (Figure 1E–G). Mutations in eEF1A (such as in
tef2-9) lead to defects in translation elongation (31), which
is reflected in polysomal profiles of sucrose-density gradi-
ent fractionations that were prepared without the usual ad-
dition of cycloheximide. Under such conditions, wild-type
cells continue elongation, leading to a complete polysome
run-off, while elongation factor mutants stall ribosomes
during elongation on the mRNA, thereby preventing their
arrival at the stop codon (Figure 1E) (32). Western blot
analyses of the corresponding protein fractions show that
high amounts of Rli1 are present in the mono- and polyso-
mal factions in tef2-9 cells, similar to the ribosome-bound
protein Asc1 (Figure 1G). This finding is in agreement with
structural analyses of the human homolog of Rli1, ABCE1
at the ribosome, which show that the protein binds to the
intersubunit space of the ribosome where aEF1 also asso-
ciates (29), suggesting that their binding is mutually exclu-
sive. However, as stalled ribosomes have free A-sites when
the elongation factor is inactivated as in the tef2-9 mutant,
different factors can stochastically go there, among them
Rli1. These findings suggest that Rli1 can bind to the ribo-
some as soon as the A-site is free and thus might be the first
termination factor that enters the ribosome, which is clearly
earlier than anticipated. In contrast to that, Dbp5 is almost
absent in the polysome fractions of tef2-9 cells (Figure 1F
and G), indicating that Dbp5 is recruited to ribosomes only
after translation elongation. Thus, our results suggest that
the ribosomal association of Dbp5 not only requires a free
A-site like this is the case for Rli1, because in contrast to
Rli1 Dbp5 is not associated with ribosomes in an elonga-
tion mutant, but Dbp5 recruitment also seems to depend
on a stop codon and functional eRF1.
Dbp5 and Rli1 interact with each other during translation ter-
mination
Although both Rli1 and Dbp5 were identified as transla-
tion termination factors (10,13), it is unclear whether they
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Figure 1. Dbp5, but not Rli1, requires eRF1 to associate with the ribosome at a stop codon. (A) The interaction of Rli1 with the ribosome is not dependent
on eRF1. Western blot analysis of Rli1 co-IPs in wild-type and sup45-2 cells shifted to 37◦C for 1 h reveal co-precipitation of the small ribosomal protein
uS3 ( = Rps3) and the large ribosomal protein uL29 ( = Rpl35). Detection of Zwf1 served as non-binding control. (B) The interaction of Dbp5 with
ribosomal subunits is decreased in sup45-2. Western blot analysis shows co-precipitation of uS3 and uL29 with Dbp5 IPs in wild-type and sup45-2 cells,
shifted to 37◦C for 1 h. (C) The interaction of mutant eRF1 with the ribosome is decreased. Western blot analysis of the co-precipitation of mutant eRF1
(sup45-2) with uL23 (top) or with uS3 (bottom) is shown. Aco1 served as a negative control. (D) Quantification of at least three independent experiments,
one of which is shown in panels (A–C), which determine the amount of the co-precipitated proteins, measured with the Fusion SL detection system. (E)
Ribosome profiles of wild-type and the translation elongation defective strain tef2-9 reflects the translational run-off in wild-type and a translational arrest
in the elongation mutant. Wild-type and tef2-9 cells were shifted to 37◦C for 1 h before the lysates were analysed in linear sucrose-density gradients without
cycloheximide. (F) Rli1, but not Dbp5, is bound to ribosomes during translation elongation. Western blot analysis of the fractions, representing the total
cellular amount of the indicated proteins, reveals their ratio in the 80S, polysomal or non-ribosomal, 40S and 60S fractions. Asc1 as a ribosome binding
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Figure 2. Rli1 supports the recruitment of Dbp5 and eRF1 to the ribosome. (A) Dbp5 interacts RNA-independently with Rli1. Immunoprecipitation of
TAP-Dbp5 in the presence of RNase A shows co-precipitation of Rli1-HA in western blot analysis. Detection of eRF1 served as positive and of Por1 as
negative control. (B) The interaction between Rli1 and Dbp5 is decreased in sup45-2, shifted to 37◦C for 1 h. Western blot analyses of Rli1-IPs reveal
less co-precipitation of Dbp5, but no reduction of the ribosomal protein uS3 in sup45-2 compared to wild-type. Cdc28 served as negative control. (C)
Quantification of four different experiments shown in panel (B). (D) Inhibition of translation elongation leads to a reduced interaction between Rli1
and Dbp5. Western blot analyses of co-IPs of Dbp5 with Rli1 upon treatment with 0.5 mg/ml cycloheximide (CHX) for 30 min are shown. Hem15 was
detected as non-binding control. (E) Quantification of three different experiments shown in panel (D). (F) Overexpression of RLI1 partially rescues the
growth defects of sup45-2, while the wild-type growth is not influenced. Serial dilutions of the indicated strains are shown upon growth on selective plates
for 3 days at 35◦C. (G) Overexpression of RLI1 suppresses the binding defect of eRF1 to the ribosome in sup45-2 cells. Co-IPs of eRF1 with uS3-GFP are
shown in the indicated strains with or without high copy (HC) RLI1. (H) Quantification of four different experiments shown in panel (G); *P < 0.05; **P
< 0.01; ***P < 0.001.
precipitated Rli1 with Dbp5 in vivo (Figure 2A) and vice
versa Dbp5 as well as its co-factor Gle1 with Rli1 (Supple-
mentary Figure S1B) unrevealing a physical interaction be-
tween Dbp5 and Rli1 that might be direct or mediated by
other proteins. To verify that this interaction actually occurs
during translation termination and not for instance dur-
ing pre-ribosomal subunit export from the nucleus in which
Rli1 and Dbp5 are both involved (18,19,21), we compared
their interaction in sup45-2 cells in which the termination
process is inhibited and Dbp5 does not enter the ribosome.
Our results show that in sup45-2 the interaction of Rli1 and
Dbp5 is indeed reduced to more than half, while its inter-
action to the ribosome is not decreased (Figure 2B and C).
Moreover, we treated wild-type cells with the antibiotic cy-
cloheximide, which inhibits translation elongation and thus,
prevents ribosomes from arriving at stop codons, reflected
in the ribosomal profiles. Also in this case the prevention of
translation termination leads to a significantly decreased as-
sociation ofRli1 andDbp5 (Figure 2DandE). These results
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Figure 3. Not eRF1 and eRF3 enter the ribosome together, but eRF1 and Dbp5. (A) The binding of Dbp5 with the ribosome-binding defective protein
sup45-2 is increased, while its ribosome association is decreased. Western blot analyses of co-IPs with mutated eRF1 (sup45-2) and Dbp5 or uL29 are
shown. Detection of Hem15 served as a non-binding control. (B) The interaction between eRF3 and eRF1 is decreased in the sup45-2 strain as shown in
western blots of the eRF1 co-IP with eRF3. Por1 served as negative control. (C) Quantification of three different experiments shown in panels (A) and (B).
(D) The interaction of eRF1 and eRF3 is decreased in a DBP5 mutant. Western blot analysis of eRF3 co-IPs with eRF1 in wild-type and the rat8-2 stain
is shown. (E) Quantification of three different experiments shown in (D); *P < 0.05; **P < 0.01; ***P < 0.001.
during translation termination and that both proteins bind
simultaneously to the termination complex, possibly dur-
ing stop codon recognition. This finding contradicts older
models, in which Rli1 binds only for ribosome recycling.
An in vivo interaction of Dbp5 and eRF1 was shown ear-
lier (10). However, as Rli1 most likely binds to the ribosome
before Dbp5 and eRF1 have entered (Figure 1), we won-
dered whether Rli1 might support their recruitment to the
ribosome. We therefore investigated if an overexpression of
RLI1 would suppresses the sup45-2 mutant, which has de-
fects in ribosome binding (Figure 1C and D), (30). Indeed,
growth analyses show at least a partial rescue of the sup45-
2 growth defects in the presence of high copy RLI1 (Fig-
ure 2F). The reason for this suppression might be that an
increased amount of Rli1 proteins leads to their faster ri-
bosome binding, which supports the defective sup45 pro-
tein in associating with the ribosome. This seems indeed to
be the case as shown by co-IPs (Figure 2G). While the as-
sociation of the mutated eRF1 protein with the ribosome
is reduced to a quarter, increased Rli1 concentrations sup-
port the binding of sup45-2 to more than 60% (Figure 2H).
These findings suggest that the initial presence of Rli1 at the
ribosome could support the subsequent eRF1 recruitment
to the stop codon.
eRF1 and eRF3 do not enter the termination complex to-
gether
In contrast to Rli1, Dbp5 requires intact eRF1 for its bind-
ing to the ribosome (Figure 1). From previous studies, it
was suggested that Dbp5 might help to position eRF1 at
the stop codon and dissociate before eRF3 enters the termi-
nation complex (10). Thus, it seems conceivable that eRF1
and eRF3 are not recruited as a complex, but rather individ-
ually, which challenges current models. To analyse whether
Dbp5 and eRF1 form a complex already in the cytoplasm,
we took again advantage of the sup45-2 mutant, in which
the mutated eRF1 protein sup45-2 has a ribosome-binding
defect and is thus detached and freely present in the cyto-
plasm at the non-permissive temperature (Figure 1C and
D) (30) and analysed its binding to Dbp5. Indeed, co-IPs
revealed an increased binding of the cytoplasmic sup45-
2 to Dbp5 (Figure 3A and C), while at the same time its
interaction to eRF3 is decreased (Figure 3B and C). Re-
markably, despite the fact that the sup45-2 protein is less
stable as compared to wild-type eRF1, as reflected in the
lysate lanes, its binding to Dbp5 is significantly increased.
These results could suggest that a pre-formed complex of
Dbp5 and eRF1 in the cytoplasm approaches the termi-
nating ribosome, while eRF3 enters separately upon Dbp5-
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Figure 4. Nup159 recycles Dbp5-ATP also for translation termination. (A) Scheme of the reporter plasmids used in the dual reporter -galactosidase
luciferase assay. The lacZ gene, expressing -galactosidase and the luc gene, expressing luciferase is either separated by the stop codon UAG or in frame. In
the upper case, luciferase will only be expressed in case the stop codon is readthrough. The in-frame reporter serves as control to monitor basal expression
levels and relate it to the stop codon containing construct. (B)Mutants ofNUP159 show increased readthrough of the stop codon. The average readthrough
activity of at least three independent experiments is shown after shift of all indicated strains to 37◦C for 30 min. (C) High copyDBP5 rescues the increased
stop codon readthrough of rat7ΔN. All strains were shifted to 37◦C for 30min. (D) The interaction of Dbp5 and eRF1 is disturbed in the recycling defective
mutant rat7ΔN. Western blot analysis of a co-IP with Dbp5 and eRF1 is shown. Aco1 served as a negative control. (E) Quantification of three different
experiments shown in panel (D). (F) The interaction of eRF1 and eRF3 and the ribosome is diminished in rat7ΔN cells. Western blot analysis of a co-IP
with eRF1-GFP and eRF3 or the ribosome bound protein Asc1 is shown. (G) Quantification of three different experiments shown in panel (F). (H) Dbp5
and eRF1 directly interact in the presence of a non-hydrolysable ATP-analogue. An in vitro binding study with recombinant proteins in which GST-tagged
Dbp5 or eRF3 were used in pull-down experiments in the presence of His-eRF1 and if indicated 1 mMAMP–PNP is shown in western blot analysis. GST
alone served as a non-binding control; *P < 0.05; **P < 0.01; ***P < 0.001.
a complex formation between the three termination factors
is unlikely or their potential contact is very short.
To further investigate whether Dbp5might indeed deliver
eRF1 to the ribosome and eRF1 and eRF3 do not enter the
ribosome together, we analysed if mutations inDBP5would
lead to a reduced binding of eRF1 to eRF3 and to the ribo-
some. For this purpose, we used the rat8-2 strain that pro-
duces instable Dbp5 protein due to a leucine to proline ex-
change at position 267 (33) (Figure 6H). Indeed, in vivo in-
teraction studies of eRF1 and eRF3 in rat8-2mutants reveal
a ∼70% reduction of eRF1 binding to the ribosome and to
eRF3 upon a 1 h temperature shift to 37◦C (Figure 3D and
E). The reduced eRF1 and eRF3 interaction was also de-
tected earlier and seems to happen immediately, already af-
ter a 20 min temperature shift of the rat8-2 strain. However,
the ribosomal binding of eRF1was less obviously decreased
after this short shifting time (10). But the longer 1 h shift
produces a clear ribosome binding defect of eRF1 (Figure
3D and E). Together, our findings suggest that Dbp5 might
deliver eRF1 to the ribosome without eRF3.
Nup159 recycles Dbp5–ADP for export and translation ter-
mination
The ATPase activity of Dbp5 is essential not only for
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(10,16,17). During termination, we suggest that the helicase
might deliver eRF1 and it seems possible that it could use
its ATPase-dependent activity to position eRF1 properly
on the stop codon. In particular, because we have shown
earlier that its ATPase activity is necessary not only for its
function in mRNA export, but also for its role in transla-
tion termination (10). In both cases, upon ATP-hydrolysis,
the enzyme needs to be recycled. During mRNA export,
the nucleoporin Nup159/Rat7 is the ADP-release factor of
Dbp5 (17). Thus, it is conceivable that recycling from ter-
mination also occurs at the NPC via Nup159, rather than
at the ribosome. In particular, because Dbp5 must return
to the cytoplasm to capture a new molecule of eRF1 as
they first interact in the soluble fraction of the cytosol (Fig-
ure 1). Indeed, readthrough experiments with a dual -
galactosidase luciferase reporter system show an increased
readthrough activity in different nup159mutants, very sim-
ilar to the dbp5 mutant rat8-2 (Figure 4A and B), (10).
As both nup159 mutants, rat7-1 and rat7ΔN, the latter of
which specifically lacks the interaction domain for Dbp5
(34), exhibit increased readthough activities as compared
to wild-type (Figure 4B), Nup159 seems to be the recycling
factor for Dbp5 not only for mRNA export, but also for
translation termination. In support of this model, we found
that overexpression of DBP5 leads to a rescue of the high
readthrough activity in rat7ΔN cells (Figure 4C) indicating
that less recycling by Nup159 is needed when more Dbp5–
ATP is present.
These results suggest that Nup159 recycles Dbp5–ADP
also upon its action in translation termination, which is
quite attractive, because in this way Dbp5 might couple two
important cellular processes––nuclear mRNA export and
translation. When the translation rate is low, Dbp5 is free
to increasingly act in mRNA export to raise the mRNA
amount in the cytoplasm and vice versa, high translation
rates could reducemRNAexport. To verify a dependence of
the eRF1–Dbp5 interaction on Nup159, because their con-
tact should only be established when Dbp5 is ATP-bound,
we performed co-IPs with these proteins in rat7ΔN. Indeed,
while the interaction of Dbp5 and eRF1 was clearly de-
tectable in wild-type, it was significantly reduced in rat7ΔN
(Figure 4D and E), supporting a model in which Dbp5 is
recycled at the NPC with ATP. These findings further sug-
gest that Dbp5–ATP can bind eRF1, while Dbp5–ADP
might release the termination factor. As Dbp5 could not
be re-charged in rat7ΔN and thus cannot deliver eRF1 to
the ribosome anymore, the interaction of eRF1 with eRF3
should also be decreased in this mutant, which is indeed the
case as shown by co-IPs (Figure 4F and G).
The switch in eRF1 binding and release through ATP-
hydrolysis of Dbp5 was further investigated in in vitro ex-
periments with purified recombinantly expressed proteins.
We show that Dbp5 only binds to eRF1 in the presence of
the non-hydrolysable ATP-analogue AMP–PNP, whereas
eRF3 interacts also ATP-independently with eRF1 (Figure
4H). Together, these in vivo and in vitro studies support a
model in which eRF1 associates with Dbp5–ATP in the cy-
toplasm and dissociates from Dbp5–ADP at the ribosome,
where Dbp5 possibly uses its ATP-dependent helicase ac-
tivity to place eRF1 properly on the stop codon. Moreover
it becomes evident that eRF1 and Dbp5 form a complex in
the cytoplasm, from which eRF3 is absent.
Binding of Dbp5 and eRF3 to eRF1 is mutually exclusive
As Dbp5 and eRF1 enter termination complexes together,
and Dbp5 does not interact with eRF3 (10), it seems possi-
ble that the binding of Dbp5 and eRF3 with eRF1 is mutu-
ally exclusive. It was shown that the eRF3-interaction do-
main of eRF1 comprises the last 25 amino acid residues of
its C-terminus (5). In vitro binding studies with recombi-
nant proteins were carried out to investigate whether this
domain is also the Dbp5-interaction domain. Indeed, while
full-length eRF1 interacts with both, eRF3 and Dbp5, no
interaction was detectable with eRF125C (Figure 5A), in-
dicating that both termination factors share the same bind-
ing site on eRF1. Interestingly, although also the middle
domain of eRF1 was reported to contribute to the eRF1–
eRF3 interaction (35), we found that the deletion of the C-
terminal domain is sufficient to abrogate the interaction of
eRF1 with eRF3 and Dbp5 in vitro. Moreover, a preformed
interaction of Dbp5 and eRF1 was not disrupted by the
addition of increasing amounts of eRF3 in a competition
assay (Figure 5B). Intriguingly, these findings suggest in-
deed a sequential and mutually exclusive binding of Dbp5
and eRF3 to eRF1 with a first complex formation between
Dbp5 and eRF1. Thus, a model is possible, in which during
the progress of termination, Dbp5–ATP prohibits the ac-
cess of eRF3 to eRF1 until eRF1 was placed properly in the
ribosomal A-site. Such a mechanism would prevent a pre-
mature access of eRF3 and a consequent premature GTP-
hydrolysis. Because as soon as eRF3 contacts its guanine
exchange factor eRF1 at the ribosome, eRF3 binds GTP,
which is subsequently hydrolysed, resulting in the immedi-
ate dissociation of eRF3 from the ribosome (36,37). The
suggested sequential entry of the termination factors would
have the advantage that the contact of eRF3 with eRF1 is
controlled, which will prevent prematureGTP-hydrolysis of
eRF3 and its subsequent premature dissociation before the
stop codon is successfully recognized.
eRF3 binds to the ribosome prior to eRF1
Protection of eRF1 from premature eRF3 access would
only be necessary if eRF3would already be present at the ri-
bosome when eRF1 enters. Therefore, we analysed its ribo-
somal association in the tef2-9mutant that arrests in trans-
lation elongation as shown in Figure 1E and F. Strikingly,
eRF3, but almost no eRF1 is detectable in the polysomal
fractions of this elongation mutant, suggesting that eRF3
can independently bind ribosomes before they arrive at a
stop codon and is therefore already present when eRF1 en-
ters (Figure 6A and B). These findings are supported by
co-immunoprecipitation analyses of eRF3 with ribosomal
proteins in the mutant sup45-2. In the situation in which
this mutant eRF1 protein accumulates with Dbp5 in the cy-
toplasm (Figure 1), the binding of eRF3 to the ribosomal
protein uS3 is not reduced, but rather increases as its eRF1
mediated GTP-hydrolysis and release is prevented (Figure
6C and D).
Because Rli1 is also present at that early time point, we
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Figure 5. Dbp5 and eRF3 interaction with eRF1 is mutually exclusive. (A) The interaction site of eRF1withDbp5 and eRF3 overlap.Western blot analyses
of pull-downs experiments with GST–Dbp5, GST–eRF3 or GST and His-eRF1 or His-eRF125 lacking the last C-terminal amino acid residues are shown.
All binding buffers contained 1 mM AMP–PNP. (B) A preformed complex of eRF1 and Dbp5 cannot be disrupted by eRF3. Western blot analysis of
a competition assay of the indicated recombinantly expressed proteins is shown. Increasing amounts of eRF3 were added to the preformed complex of
GST–Dbp5 and His-eRF1. Rli1 served as a positive control for eRF3 binding. All binding buffers for Figure 5 contained 1 mM AMP–PNP.
In vitro binding studies revealed that either nucleotide free
eRF3, or GDP-bound but not GTP-bound eRF3 directly
interacts with Rli1 (Figure 6E), (23), suggesting that Rli1
might bind to eRF3–GDP at the ribosome, where they wait
for the arrival of eRF1. Furthermore, Rli1 interacts with
eRF3 without the addition of ATP (Figure 6E), support-
ing a model in which nucleotide-free Rli1 binds to the ribo-
some and eRF3 and the recruitment of ATP to Rli1 occurs
later. As this nucleotide-free state of Rli1 was shown to re-
sult in a rather weak association with the ribosome (23), it
is conceivable that Rli1 might change its position on the ri-
bosome during the stepwise assembly of all termination fac-
tors. Upon eRF1 entry, eRF3 most likely binds to GTP, as
its affinity to the triphosphate increases upon eRF1 contact
(36,37), which would trigger its dissociation from Rli1, be-
cause it interacts only with eRF3–GDP (Figure 6E). These
rearrangements in the termination complex through eRF3–
GTP-hydrolysis stimulate the eRF1-mediated polypeptide-
and tRNA-release by moving eRF1 into its favourable po-
sition to terminate translation (37). The poly(A) binding
protein Pab1 might further support this early association
of eRF3 to the ribosome and Rli1 as eRF3 and Pab1 were
shown to interact (38,39).
Dbp5 enables a stable contact of eRF1 and eRF3 at the ribo-
some
In a model in which Dbp5 delivers eRF1 and prevents pre-
mature excess of eRF3, one would expect that in a situa-
tion in which the Dbp5 binding to eRF1 is inhibited, the re-
lease factor might be able to access the ribosome alone and
immediately contact eRF3. This situation should result in
the immediate dissociation of eRF1 and eRF3 from each
other and from the ribosome, because their contact would
not be prevented until eRF1 was properly positioned by
Dbp5. This is indeed the case. In amutant of theDbp5 recy-
cling factor Nup159, rat7ΔN, Dbp5 remains ADP-bound,
which prevents its complex formation with eRF1 (Figure
4D), or in mutant DBP5, such as rat8-2, in which the pro-
tein is detached from the NPC at 37◦C and not re-charged
with ATP (40), eRF1 is not Dbp5 bound. In both cases, the
freely available eRF1 leads to the reduced presence of eRF1
and eRF3 at the ribosome as reflected in uS3 co-IPs (Fig-
ure 6F–I). Possibly eRF1 and eRF3 are less present at the
ribosome, because both release factors instantly dissociate
upon their uncontrolled contact, because their contact ini-
tiates the GTP-binding of eRF3, its subsequent hydrolysis,
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Figure 6. eRF3–GDP binds Rli1 prior to the entry of Dbp5 and eRF1. (A) eRF3 is present on ribosomes stalled in translation elongation. Western blot
analysis of the collected fractions of the tef2-9 gradient shown in Figure 1E with antibodies against eRF3, eRF1 and Asc1 are displayed. (B) Quantification
of four different western blot analyses shown in panel (A). (C) Ribosome binding of eRF3 in sup45-2 is increased. Western blot analysis of co-IPs of eRF3
and the positive control Asc1 with uS3 (top) and uL29 (bottom) are shown. (D) Quantification of four different IPs shown in (C). (E) Rli1 binds nucleotide
free eRF3 directly and releases eRF3-GTP. Western blot analysis of in vitro pull-down experiments with Rli1 is shown. (F–I) The ribosomal association
of eRF1, eRF3 and Dbp5 is decreased in nup159 (F and G) or dbp5 (H and I) mutants. Western blot analyses of the uS3-co-precipitated proteins in the
indicated strains are shown. (G and I) Quantification of four (G) and three (I) different IPs shown in panels (F) and (H), respectively. (J) Defects in eRF1
delivery partially suppresses the growth defects of trp5Δ. Serial dilutions of the indicated strains are shown upon growth on full medium agar plates at the
indicated temperatures; *P < 0.05; **P < 0.01; ***P < 0.001.
premature contact would support the observed increased
readthrough activity (Figure 4B and C).
It is quite intriguing thatDbp5 controls the entry of eRF1
into termination reactions. However, this novel function
might have an impact not only at termination codons on
readthrough activity, but also on termination events at near
cognate codons, such as the UGG tryptophan codon that
is similar to the stop codon UGA. In such situation it is
observed that mRNA translation is not continued and in-
stead translation termination occurs. To investigate whether
Dbp5 would genetically interact with the tryptophan syn-
thetasemutant trp5Δ, we generated the rat8-2 trp5Δ double
mutant andmonitored the growth at different temperatures.
We found that the double mutant partially suppresses both
single mutants at 16◦C and rat8-2 strain also at higher tem-
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tations in DBP5 indeed affect termination events at near
cognate codons and the deleterious effect of the trp5 dele-
tion stems from inefficient decoding of UGG codons, and
increased eRF1-catalysed mistermination events on such
codons. This effect appears suppressed in rat8-2 mutants
where the delivery of eRF1 to such codons would be re-
duced (Figure 6J).
eIF3 enters translation termination after the Dbp5-mediated
delivery of eRF1
In addition to eRF1, eRF3, Rli1 and Dbp5, the transla-
tion initiation factor, eIF3with its subunit Hcr1 were shown
to participate in translation termination (15). Mutations
in eIF3 reduce the rate of stop codon readthrough, while
hcr1Δ shows an increased readthrough activity and this
phenotype was suppressed by high copy Rli1. A model was
proposed in which Hcr1 is not a bona fide translation ini-
tiation factor, but rather acts in termination by promot-
ing GDP–eRF3 ejection from the ribosomes (15). In such
a model Dbp5 would not bind to Hcr1, because it would
dissociate before Hcr1 would contact eRF3. To investigate
this, we carried out co-IPs with Hcr1 and Dbp5 and could
confirm theHcr1 eRF3 interaction, while no interaction be-
tweenHcr1 andDbp5was visible (Figure 7A). Interestingly,
also the interaction of Hcr1 with the ribosome is less strong
as that of eRF1, supporting the model that Hcr1 ejects
eRF3 from the ribosome. eIF3 was suggested to promote
ribosome recycling after termination. As such, one would
expect the complex to bind after translation termination.
Indeed, one of the eIF3 subunits Prt1 clearly interacts with
Rli1, eRF3, eRF1 and the ribosome, represented by Asc1
in wild-type cells, but these interactions were abrogated in
sup45-2 cells, in which the termination reaction does not oc-
cur (Figure 7B). A Dbp5 Prt1 interaction was not detected,
which might suggest that a potential interaction is either
rather short or Prt1 associates only after Dbp5 has deliv-
ered eRF1. We further show in co-IPs that the interaction
of eIF3 with Rli1 and the ribosome is independent on the
ATP-binding of Rli1, because both eIF3 subunits, Prt1 and
Nip1 interact without or with the addition of AMP–PNP
(Figure 7C).
These data support the following stepwise entry model
for translation termination in yeast (Figure 8). Nucleotide-
free Rli1 binds to the ribosome as soon as the A-site is un-
occupied. eRF3–GDP associates with Rli1 and waits for
the entrance of eRF1. Rli1 furthermore supports the en-
try of eRF1 into the ribosome, which is delivered and po-
sitioned at the stop codon by the helicase Dbp5. The con-
tact of eRF3 and eRF1 is controlled by the dissociation of
Dbp5, which occurs upon hydrolysis of its ATP through
Gle1- and IP6-stimulation. ADP–Dbp5 recycling is medi-
ated at the NPC through Nup159, which couples transla-
tion to mRNA-export. Dissociation of Dbp5 allows con-
tact of eRF1 and eRF3, which stimulates eRF3 to associate
with GTP and induces a stronger binding to Rli1, which
might indicate that Rli1 changes its position. The subse-
quent GTP-hydrolysis of eRF3 results in the final position-
ing of eRF1, dissociation of eRF3–GDP by Hcr1, which
is delivered by eIF3 to the ribosome and to peptidyl-tRNA
hydrolysis and polypeptide chain release from the ribosome.
Subsequent recycling of the ribosomal subunits is mediated
by Rli1 (4,23,26).
DISCUSSION
Translation termination depends on the two key factors
eRF1 and eRF3, but also on Dbp5 and Rli1 (10,13). How-
ever, their function and the order in which the termination
complex assembles, was unclear. Current models suggest
that eRF1 and eRF3 enter the ribosome together as a com-
plex (1,2,4), but we show here that this is very unlikely and
propose a new translation termination model in which the
termination complex assembles stepwise (Figure 8).
Polysomal gradients and co-IPs indicate that nucleotide-
free Rli1 and eRF3–GDP binds to the ribosome prior to
eRF1 and Dbp5 entry (Figures 1 and 6). Our data support
a function of Rli1 in promoting the recruitment of the other
termination factors. In particular, it promotes the binding
of the Dbp5–eRF1 complex leading to the formation of
a ternary complex with Rli1 (Figures 2F–H and 6E). For
such a function, Rli1 would not require its ATPase activ-
ity, which is in agreement with earlier studies in which it
was shown that ATP-hydrolysis by Rli1 does not take place
during the termination process (4,13). It was furthermore
suggested earlier that Rli1 associates with the termination
complex upon dissociation of eRF3–GDP, taking over its
position to lock eRF1 in its favourable position to facilitate
peptidyl-tRNA hydrolysis (4,26). In contrast to this model,
we present evidence that Rli1 and eRF3–GDP are the ini-
tial components of the termination complex that bind to
the ribosome. However, our data are in agreement with a
model in which in the course of the stepwise assembly, Rli1
could take over the position of eRF3, because initially eRF3
binds to Rli1 in its GDP bound form and dissociates upon
GTP binding and hydrolysis (Figure 6E), which could allow
the remodelling of the complex and enable Rli1 to occupy
the eRF3 position upon its release. Because Rli1 is most
likely nucleotide-free in this early stage of translation termi-
nation (Figure 6E), it is conceivable that the rearrangements
upon eRF3 dissociation might be supported by its binding
to ATP, which is later on required for the splitting of the ri-
bosomal subunits (23,24). However, it is also possible that
the entry of eIF3 and/or the dissociation of eRF3 through
Hcr1 (Figure 7A–C) induce these rearrangements.
In contrast to earlier models, our results furthermore
indicate that Dbp5–ATP captures eRF1 in the cytoplasm
(Figures 3A,C and 4D) and delivers it to the stop codon-
bound ribosome on which eRF3–GDP and Rli1 are al-
ready present (Figures 1F,G and 6A,B). The interaction be-
tween Rli1 and Dbp5 might thereby support the Dbp5–
eRF1 recruitment (Figure 2). Upon placing eRF1 prop-
erly on the stop codon, Dbp5–ADP dissociates and is re-
cycled at the NPC via Nup159 (Figure 4). In this way, the
two key processes of mRNA export and translation are
coupled via Dbp5. How the duty of Dbp5 in both pro-
cesses is divided and how Dbp5 captures eRF1 is currently
unclear and needs further investigation. Interestingly, the
overall cellular protein abundance estimates suggest an in-
tracellular Dbp5:eRF1:eRF3 ratio of ∼1:2:4 (https://www.
yeastgenome.org/). Dbp5 as a limiting factor further quali-
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Figure 7. The eIF3 complex binds to the ribosome after the Dbp5-mediated delivery of eRF1. (A) The eRF3 release factor Hcr1 does not bind to Dbp5
and only weakly to the ribosome. Co-IPs with GFP-tagged Hcr1 and as a control eRF1–GFPwith Dbp5, eRF3 and the ribosomal protein Asc1 are shown.
The asterisk indicates Hcr1–GFP. (B) Defects in the eRF1 delivery result in the absence of the eIF3 subunit Prt1 at the ribosome. Co-IPs of GFP-tagged
Prt1 with HA-tagged Rli1, eRF1, Dbp5, eRF3 and the ribosomal protein Asc1 are shown in wild-type and sup45-2 strains. The asterisk indicates that the
sup45-2 lysate lanes were exposed four times as long as the wild-type lanes. (C) The binding of the eIF3 subunits Prt1 and Nip1 are independent of the
nucleotide association of Rli1. The GFP-tagged eIF3 subunits were precipitated and the co-precipitated GST-tagged Rli1 and Asc1 are shown.
eRF3, because only theDbp5-delivered eRF1 can engage in
proper termination events. Excess of eRF1 overDbp5might
be required, because it participates also in ribosome recy-
cling (4,23,26) and thus remains bound for a longer time.
The high amounts of eRF3 might be required, because it
waits on every ribosome at late stages of elongation (Figure
6A and B) for eRF1 to enter. In support of this view, it is
interesting to note that a 20% decrease of the basal cellular
protein levels of Dbp5 or eRF1 already negatively impact
protein biosynthesis, while a 60% decrease of eRF3 has no
effect (14). Thus, theDbp5-mediated delivery of eRF1 is the
rate-limiting step, supporting a view that Dbp5 controls the
termination event.
Interestingly, our in vivo results clearly show that Dbp5 is
not bound to the ribosome during elongation (Figures 1F,
G, 2D and E), although its human homolog DDX19 has
been shown to stabilize translation elongation in vitro (14).
This might either be a difference between the human and
the yeast helicase, but it is also conceivable that in the in vivo
situation a contact of Dbp5 with the elongating ribosome is
prevented and its recruitment is only possible when bound
to eRF1.
Importantly, the simultaneous entry of Dbp5 and eRF1
in a complex has the advantage that Dbp5 protects eRF1
from premature access to eRF3, because Dbp5 occupies the
binding domain of eRF3, located at the last 25 amino acid
residues of the C-terminal domain (Figure 5). This is par-
ticularly important, because eRF3 is already present at the
ribosome, when Dbp5–eRF1 enters (Figure 6A and B). In
fact, a separated entry of eRF1 and eRF3 is actually sup-
ported by earlier studies, showing that a reduced eRF3 ex-
pression does not lead to a decreased ribosomal association
of eRF1 (3).
In situations of defective Dbp5 or Dbp5–ATP recycling,
as in the rat8-2 and nup159ΔN mutants, respectively, the
protected eRF1 delivery to the ribosome cannot occur and
eRF1 can contact eRF3 prior to its proper positioning and
stop codon recognition. This contact would induce eRF3
to release GDP and bind GTP, because the affinity of eRF3
to GTP strongly increases upon eRF1 contact (36,37). This
in turn can trigger the premature GTP-hydrolysis and sub-
sequent dissociation of eRF3–GDP and eRF1 from each
other and the ribosome (Figure 6F–I), as evident in these
mutants (Figures 3D, E, 4F and G). In support of such
a model, it is interesting to note that a reduced binding
of eRF3 to polysomes was already detected in rat8-2 cells
upon a very short, 20 min temperature shift to the non-
permissive temperature and in mutants of the co-factor of
Dbp5, GLE1 (10,12). As eRF1 would not have been prop-
erly positioned when Dbp5 cannot deliver it, stop codon
recognition, polypeptide chain- and tRNA-release would
be unsuccessful and translation might be continued with
near-cognate tRNAs, resulting in the observed readthrough
activity in nup159 and dbp5 mutants (Figure 4B and C).
Longer temperature shifts of both mutants and thus con-
stant defects in stop codon recognition and mRNA trans-
port cannot be tolerated and are lethal to cells (33,34).
Dbp5 not only impacts stop codon readthrough, but also
controls the delivery of eRF1 to near-cognate codons, such
as the UGG tryptophan codon, suggested by its suppres-
sion of the trp5Δ strain (Figure 6J). This supports a view,
inwhichDbp5 controls the delivery of eRF1. This discovery
further suggests that cells may use this system to trigger stop
codon readthrough in particular situations. Stress for ex-
ample changes the expression program of cells, as it blocks
bulk mRNA export, while it allows the uncontrolled export
of stress specific mRNAs (41,42). Such massive changes in
the cellular expression program might also involve Dbp5.
Intriguingly, it was reported that Dbp5 mislocalizes to the
nucleus upon ethanol stress (43), which would circumvent
the helicase to support efficient termination and rather pro-
mote the readthrough of stop codons. Also during glucose
starvation, in which the ATP-production is reduced, Dbp5
is most likely not efficiently re-charged with ATP, which in
turn should reduce the Dbp5-mediated eRF1 delivery and
result in an increased readthrough of stop codons.
Generally, stop codon readthrough has the potential to
create proteins with new or additional functions. Extended
C-termini could for instance add nuclear localization sig-
nals to normally cytoplasmic proteins and in this way re-
direct them to the nucleus. It is also possible that the
longer protein is unstable and quickly degraded. Moreover,
when no additional stop codon is present in an mRNA
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Figure 8. Stepwise entry model for translation termination. (Top) Step 1: Nucleotide-free Rli1 associates with the ribosomes as soon as the A-site is free.
It binds to eRF3–GDP. Step 2: Rli1 supports the entry of Dbp5–ATP bound eRF1. Gle1/IP6 stimulated ATP-hydrolysis of Dbp5–ATP leads to the
proper positioning of eRF1 on the stop codon. Dbp5–ADP dissociates and is recycled at the nuclear pore complex by Nup159. Step 3: Dissociation of
Dbp5–ADP allows the controlled interaction of eRF1 with eRF3. This in turn triggers the GTP recruitment of eRF3. Subsequent GTP hydrolysis leads to
conformational changes in eRF1 allowing adjustments in its positioning in the ribosomal peptidyl-transferase center. eRF3–GDP dissociates in a complex
with Hcr1, which was delivered by eIF3. Step 4: eRF3–GDP dissociation allows change of position and strong binding of Rli1–ATP that locks eRF1 in the
position necessary to mediate peptidyl-tRNA hydrolysis. Step 5: Upon peptide release, ATP-hydrolysis of Rli1–ATP recycles the ribosomal subunits, which
is supported by eRF1. (Bottom) Situation in which Dbp5 cannot deliver eRF1 to the ribosome that consequently results in the stop codon readthrough.
Step1: Rli1 associates and binds eRF3–GDP. Step 2: eRF1 is not protected by Dbp5 and contacts eRF3 before being properly positioned, leading to
premature GTP-binding, hydrolysis and the subsequent release of eRF1 and eRF3–GDP from the ribosome before the polypeptide chain and the tRNA
are released. Because eRF1 had contact to eRF3 before it was placed in the optimal position, it dissociates at the same time as eRF3. Step3: A near-cognate
tRNA gets access to the A-site, the stop codon is suppressed and translation elongation continues until the next stop codon is reached.
mRNA into the poly(A) tail. In such cases, the consequence
is the degradation of the protein and the mRNA by the no-
stop decay (NSD) system (44). In higher eukaryotes e.g.
in Drosophila or mammals, stop codon readthrough oc-
curs also during developmental processes and is called func-
tional translational readthrough (FTR) (45,46). In these
cases, the stop codons are suppressed and treated as sense
codons due to the competition between eRF1 and near-
cognate tRNAs at the A-site. It is tempting to speculate that
Dbp5/DDX19 might be involved in regulating such pro-
cesses.
Most interestingly, one-third of all inherited disorders
are caused by protein truncating pre-termination mutations
that lead to non-functional proteins or cause dominant neg-
ative effects, leading to cancer and neurodegenerative dis-
eases (47,48). Nonsense suppression therapies comprise ap-
proaches aiming at suppressing translation termination at
in-frame premature stop codons to restore the deficient pro-
tein function. Using Dbp5/DDX19 as a drug target to de-
crease its function and increase readthrough at premature
stop codons for suppression therapy might be a novel start-
ing point for therapies.
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